ID   MARK4_HUMAN             Reviewed;         752 AA.
AC   Q96L34; Q8NG37; Q96JG7; Q96SQ2; Q9BYD8;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   10-MAY-2017, entry version 162.
DE   RecName: Full=MAP/microtubule affinity-regulating kinase 4;
DE            EC=2.7.11.1 {ECO:0000269|PubMed:14594945, ECO:0000269|PubMed:15009667, ECO:0000269|PubMed:23184942};
DE   AltName: Full=MAP/microtubule affinity-regulating kinase-like 1;
GN   Name=MARK4; Synonyms=KIAA1860, MARKL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=11326310; DOI=10.1038/sj.neo.7900132;
RA   Kato T., Satoh S., Okabe H., Kitahara O., Ono K., Kihara C.,
RA   Tanaka T., Tsunoda T., Yamaoka Y., Nakamura Y., Furukawa Y.;
RT   "Isolation of a novel human gene, MARKL1, homologous to MARK3 and its
RT   involvement in hepatocellular carcinogenesis.";
RL   Neoplasia 3:4-9(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   COFACTOR, INTERACTION WITH GAMMA-TUBULIN, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=14594945; DOI=10.1074/jbc.M304528200;
RA   Trinczek B., Brajenovic M., Ebneth A., Drewes G.;
RT   "MARK4 is a novel microtubule-associated proteins/microtubule
RT   affinity-regulating kinase that binds to the cellular microtubule
RT   network and to centrosomes.";
RL   J. Biol. Chem. 279:5915-5923(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=15009667; DOI=10.1046/j.1471-4159.2003.02228.x;
RA   Schneider A., Laage R., von Ahsen O., Fischer A., Rossner M.,
RA   Scheek S., Grunewald S., Kuner R., Weber D., Kruger C., Klaussner B.,
RA   Gotz B., Hiemisch H., Newrzella D., Martin-Villalba A., Bach A.,
RA   Schwaninger M.;
RT   "Identification of regulated genes during permanent focal cerebral
RT   ischaemia: characterization of the protein kinase 9b5/MARKL1/MARK4.";
RL   J. Neurochem. 88:1114-1126(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Beghini A., Magnani I., Roversi G., Piepoli T., DiTerlizzi S.,
RA   Pollo B., Conti A.M.F., Cowell J.K., Finocchiaro G., Larizza L.;
RT   "Neural progenitor-restricted isoform of MARKL1 gene is upregulated by
RT   19q13 amplification in human glioblastoma.";
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=11347906; DOI=10.1093/dnares/8.2.85;
RA   Nagase T., Nakayama M., Nakajima D., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XX.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 8:85-95(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Thyroid;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   ENZYME REGULATION, PHOSPHORYLATION AT THR-214, AND MUTAGENESIS OF
RP   THR-214.
RX   PubMed=14976552; DOI=10.1038/sj.emboj.7600110;
RA   Lizcano J.M., Goeransson O., Toth R., Deak M., Morrice N.A.,
RA   Boudeau J., Hawley S.A., Udd L., Maekelae T.P., Hardie D.G.,
RA   Alessi D.R.;
RT   "LKB1 is a master kinase that activates 13 kinases of the AMPK
RT   subfamily, including MARK/PAR-1.";
RL   EMBO J. 23:833-843(2004).
RN   [8]
RP   UBIQUITINATION, DEUBIQUITINATION BY USP9X, AND INTERACTION WITH USP9X.
RX   PubMed=18254724; DOI=10.1042/BJ20080067;
RA   Al-Hakim A.K., Zagorska A., Chapman L., Deak M., Peggie M.,
RA   Alessi D.R.;
RT   "Control of AMPK-related kinases by USP9X and atypical
RT   Lys(29)/Lys(33)-linked polyubiquitin chains.";
RL   Biochem. J. 411:249-260(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF THR-214.
RX   PubMed=23184942; DOI=10.1074/jbc.C112.396903;
RA   Li L., Guan K.L.;
RT   "Microtubule-associated protein/microtubule affinity-regulating kinase
RT   4 (MARK4) is a negative regulator of the mammalian target of rapamycin
RT   complex 1 (mTORC1).";
RL   J. Biol. Chem. 288:703-708(2013).
RN   [11]
RP   FUNCTION, INTERACTION WITH ODF2, AND SUBCELLULAR LOCATION.
RX   PubMed=23400999; DOI=10.1083/jcb.201206013;
RA   Kuhns S., Schmidt K.N., Reymann J., Gilbert D.F., Neuner A., Hub B.,
RA   Carvalho R., Wiedemann P., Zentgraf H., Erfle H., Klingmuller U.,
RA   Boutros M., Pereira G.;
RT   "The microtubule affinity regulating kinase MARK4 promotes axoneme
RT   extension during early ciliogenesis.";
RL   J. Cell Biol. 200:505-522(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-543, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23666762; DOI=10.1007/s12017-013-8232-3;
RA   Gu G.J., Lund H., Wu D., Blokzijl A., Classon C., von Euler G.,
RA   Landegren U., Sunnemark D., Kamali-Moghaddam M.;
RT   "Role of individual MARK isoforms in phosphorylation of tau at Ser262
RT   in Alzheimer's disease.";
RL   NeuroMolecular Med. 15:458-469(2013).
RN   [14]
RP   FUNCTION, DEVELOPMENTAL STAGE, AND PHOSPHORYLATION.
RX   PubMed=25123532; DOI=10.1016/j.ejcb.2014.07.004;
RA   Rovina D., Fontana L., Monti L., Novielli C., Panini N., Sirchia S.M.,
RA   Erba E., Magnani I., Larizza L.;
RT   "Microtubule-associated protein/microtubule affinity-regulating kinase
RT   4 (MARK4) plays a role in cell cycle progression and cytoskeletal
RT   dynamics.";
RL   Eur. J. Cell Biol. 93:355-365(2014).
RN   [15]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-377 AND CYS-418.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase (PubMed:15009667,
CC       PubMed:14594945, PubMed:23666762, PubMed:23184942). Phosphorylates
CC       the microtubule-associated protein MAPT (PubMed:14594945,
CC       PubMed:23666762). Also phosphorylates the microtubule-associated
CC       proteins MAP2 and MAP4 (PubMed:14594945). Involved in regulation
CC       of the microtubule network, causing reorganization of microtubules
CC       into bundles (PubMed:14594945, PubMed:25123532). Required for the
CC       initiation of axoneme extension during cilium assembly
CC       (PubMed:23400999). Regulates the centrosomal location of ODF2 and
CC       phosphorylates ODF2 in vitro (PubMed:23400999). Plays a role in
CC       cell cycle progression, specifically in the G1/S checkpoint
CC       (PubMed:25123532). Reduces neuronal cell survival
CC       (PubMed:15009667). Plays a role in energy homeostasis by
CC       regulating satiety and metabolic rate (By similarity). Promotes
CC       adipogenesis by activating JNK1 and inhibiting the p38MAPK
CC       pathway, and triggers apoptosis by activating the JNK1 pathway (By
CC       similarity). Phosphorylates mTORC1 complex member RPTOR and acts
CC       as a negative regulator of the mTORC1 complex, probably due to
CC       disruption of the interaction between phosphorylated RPTOR and the
CC       RRAGA/RRAGC heterodimer which is required for mTORC1 activation
CC       (PubMed:23184942). {ECO:0000250|UniProtKB:Q8CIP4,
CC       ECO:0000269|PubMed:14594945, ECO:0000269|PubMed:15009667,
CC       ECO:0000269|PubMed:23184942, ECO:0000269|PubMed:23400999,
CC       ECO:0000269|PubMed:23666762, ECO:0000269|PubMed:25123532}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:14594945, ECO:0000269|PubMed:15009667,
CC       ECO:0000269|PubMed:23184942}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:14594945};
CC   -!- ENZYME REGULATION: Activated by phosphorylation on Thr-214.
CC       {ECO:0000269|PubMed:14976552}.
CC   -!- SUBUNIT: Interacts with gamma-tubulin (PubMed:14594945). Interacts
CC       with ODF2 (PubMed:23400999). Interacts with USP9X
CC       (PubMed:18254724). {ECO:0000269|PubMed:14594945,
CC       ECO:0000269|PubMed:18254724, ECO:0000269|PubMed:23400999}.
CC   -!- INTERACTION:
CC       P60953:CDC42; NbExp=2; IntAct=EBI-302319, EBI-81752;
CC       Q9BYG4:PARD6G; NbExp=2; IntAct=EBI-302319, EBI-295417;
CC       Q8ND90:PNMA1; NbExp=2; IntAct=EBI-302319, EBI-302345;
CC       P41743:PRKCI; NbExp=2; IntAct=EBI-302319, EBI-286199;
CC       Q15831:STK11; NbExp=2; IntAct=EBI-302319, EBI-306838;
CC       P23258:TUBG1; NbExp=4; IntAct=EBI-302319, EBI-302589;
CC       Q04917:YWHAH; NbExp=6; IntAct=EBI-302319, EBI-306940;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:14594945}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center
CC       {ECO:0000269|PubMed:14594945}. Cytoplasm, cytoskeleton, cilium
CC       basal body {ECO:0000269|PubMed:23400999}. Cytoplasm, cytoskeleton,
CC       cilium axoneme {ECO:0000269|PubMed:23400999}. Cytoplasm
CC       {ECO:0000269|PubMed:23400999, ECO:0000269|PubMed:23666762}.
CC       Note=Localized at the tips of neurite-like processes in
CC       differentiated neuroblast cells. Detected in the cytoplasm and
CC       neuropil of the hippocampus. {ECO:0000269|PubMed:14594945,
CC       ECO:0000269|PubMed:23666762}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=MARK4L;
CC         IsoId=Q96L34-1; Sequence=Displayed;
CC       Name=2; Synonyms=MARKL1S, MARK4S;
CC         IsoId=Q96L34-2; Sequence=VSP_004946;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Isoform 2 is brain-specific
CC       (PubMed:11326310). Expressed at highest levels in brain and
CC       testis. Also expressed in heart, lung, liver, muscle, kidney and
CC       spleen (PubMed:14594945). {ECO:0000269|PubMed:11326310,
CC       ECO:0000269|PubMed:14594945}.
CC   -!- DEVELOPMENTAL STAGE: Expressed at all stages of the mitotic cell
CC       cycle. {ECO:0000269|PubMed:25123532}.
CC   -!- PTM: Ubiquitinated with 'Lys-29'- and 'Lys-33'-linked
CC       polyubiquitins which appear to impede LKB1-mediated
CC       phosphorylation. Deubiquitinated by USP9X.
CC       {ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:18254724}.
CC   -!- PTM: Phosphorylated at Thr-214 by STK11/LKB1 in complex with
CC       STE20-related adapter-alpha (STRADA) pseudo kinase and CAB39
CC       (PubMed:14976552). Phosphorylated throughout the cell cycle
CC       (PubMed:25123532). {ECO:0000269|PubMed:14976552,
CC       ECO:0000269|PubMed:25123532}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. SNF1 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB47489.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB55238.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MARK4ID419.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB049127; BAB39380.1; -; mRNA.
DR   EMBL; AB088047; BAC03375.1; -; mRNA.
DR   EMBL; AY057448; AAL23683.1; -; mRNA.
DR   EMBL; AX305105; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AX305106; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AY120867; AAM55491.1; -; mRNA.
DR   EMBL; AB058763; BAB47489.1; ALT_INIT; mRNA.
DR   EMBL; AK027619; BAB55238.1; ALT_INIT; mRNA.
DR   EMBL; AK075272; BAC11510.1; -; mRNA.
DR   CCDS; CCDS12658.1; -. [Q96L34-2]
DR   CCDS; CCDS56097.1; -. [Q96L34-1]
DR   RefSeq; NP_001186796.1; NM_001199867.1. [Q96L34-1]
DR   RefSeq; NP_113605.2; NM_031417.3. [Q96L34-2]
DR   UniGene; Hs.34314; -.
DR   PDB; 5ES1; X-ray; 2.80 A; A=44-370.
DR   PDBsum; 5ES1; -.
DR   ProteinModelPortal; Q96L34; -.
DR   SMR; Q96L34; -.
DR   BioGrid; 121760; 50.
DR   IntAct; Q96L34; 29.
DR   MINT; MINT-6425023; -.
DR   STRING; 9606.ENSP00000262891; -.
DR   BindingDB; Q96L34; -.
DR   ChEMBL; CHEMBL5754; -.
DR   GuidetoPHARMACOLOGY; 2100; -.
DR   iPTMnet; Q96L34; -.
DR   PhosphoSitePlus; Q96L34; -.
DR   BioMuta; MARK4; -.
DR   DMDM; 29840797; -.
DR   EPD; Q96L34; -.
DR   MaxQB; Q96L34; -.
DR   PaxDb; Q96L34; -.
DR   PeptideAtlas; Q96L34; -.
DR   PRIDE; Q96L34; -.
DR   DNASU; 57787; -.
DR   Ensembl; ENST00000262891; ENSP00000262891; ENSG00000007047. [Q96L34-1]
DR   Ensembl; ENST00000300843; ENSP00000300843; ENSG00000007047. [Q96L34-2]
DR   GeneID; 57787; -.
DR   KEGG; hsa:57787; -.
DR   UCSC; uc002pba.3; human. [Q96L34-1]
DR   CTD; 57787; -.
DR   DisGeNET; 57787; -.
DR   GeneCards; MARK4; -.
DR   HGNC; HGNC:13538; MARK4.
DR   HPA; HPA039186; -.
DR   MIM; 606495; gene.
DR   neXtProt; NX_Q96L34; -.
DR   OpenTargets; ENSG00000007047; -.
DR   PharmGKB; PA30641; -.
DR   eggNOG; KOG0586; Eukaryota.
DR   eggNOG; ENOG410XNQ0; LUCA.
DR   GeneTree; ENSGT00790000122947; -.
DR   HOGENOM; HOG000233025; -.
DR   HOVERGEN; HBG052453; -.
DR   InParanoid; Q96L34; -.
DR   KO; K08798; -.
DR   OMA; LAHEATP; -.
DR   OrthoDB; EOG091G0D1E; -.
DR   PhylomeDB; Q96L34; -.
DR   TreeFam; TF315213; -.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   SignaLink; Q96L34; -.
DR   SIGNOR; Q96L34; -.
DR   GeneWiki; MARK4; -.
DR   GenomeRNAi; 57787; -.
DR   PRO; PR:Q96L34; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000007047; -.
DR   CleanEx; HS_MARK4; -.
DR   ExpressionAtlas; Q96L34; baseline and differential.
DR   Genevisible; Q96L34; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0036064; C:ciliary basal body; IMP:CACAO.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005815; C:microtubule organizing center; IDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; NAS:UniProtKB.
DR   GO; GO:0043015; F:gamma-tubulin binding; IDA:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0050321; F:tau-protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0043130; F:ubiquitin binding; NAS:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0097711; P:ciliary basal body docking; TAS:Reactome.
DR   GO; GO:0030010; P:establishment of cell polarity; IEA:InterPro.
DR   GO; GO:0001578; P:microtubule bundle formation; IEP:UniProtKB.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:0007067; P:mitotic nuclear division; IEA:UniProtKB-KW.
DR   GO; GO:0007399; P:nervous system development; IDA:UniProtKB.
DR   GO; GO:0043068; P:positive regulation of programmed cell death; NAS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:UniProtKB.
DR   InterPro; IPR028375; KA1/Ssp2_C.
DR   InterPro; IPR001772; KA1_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR033624; MARK/par1.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR015940; UBA.
DR   PANTHER; PTHR24346; PTHR24346; 1.
DR   Pfam; PF02149; KA1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00627; UBA; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SMART; SM00165; UBA; 1.
DR   SUPFAM; SSF103243; SSF103243; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50032; KA1; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50030; UBA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell cycle;
KW   Cell division; Cell projection; Cilium biogenesis/degradation;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Kinase; Mitosis;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation.
FT   CHAIN         1    752       MAP/microtubule affinity-regulating
FT                                kinase 4.
FT                                /FTId=PRO_0000086307.
FT   DOMAIN       59    310       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      324    368       UBA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00212}.
FT   DOMAIN      703    752       KA1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00565}.
FT   NP_BIND      65     73       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    181    181       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      88     88       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     214    214       Phosphothreonine; by LKB1.
FT                                {ECO:0000269|PubMed:14976552}.
FT   MOD_RES     423    423       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8CIP4}.
FT   MOD_RES     543    543       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     628    752       ADEPERIGGPEVTSCHLPWDQTETAPRLLRFPWSVKLTSSR
FT                                PPEALMAALRQATAAARCRCRQPQPFLLACLHGGAGGPEPL
FT                                SHFEVEVCQLPRPGLRGVLFRRVAGTALAFRTLVTRISNDL
FT                                EL -> TLDPSKRQNSNRCVSGASLPQGSKIRSQTNLRESG
FT                                DLRSQVAIYLGIKRKPPPGCSDSPGV (in isoform
FT                                2). {ECO:0000303|PubMed:11326310,
FT                                ECO:0000303|PubMed:11347906}.
FT                                /FTId=VSP_004946.
FT   VARIANT     377    377       R -> Q (in dbSNP:rs35070611).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040766.
FT   VARIANT     418    418       R -> C (in a colorectal adenocarcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs780763668).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040767.
FT   MUTAGEN     214    214       T->A: Prevents phosphorylation and
FT                                activation by STK11/LKB1 complex.
FT                                {ECO:0000269|PubMed:14976552}.
FT   MUTAGEN     214    214       T->E: Mimicks phosphorylation state,
FT                                leading to increased activity. Decreases
FT                                mTORC1 activity.
FT                                {ECO:0000269|PubMed:14976552,
FT                                ECO:0000269|PubMed:23184942}.
FT   CONFLICT     70     70       F -> S (in Ref. 1; BAB39380/BAC03375).
FT                                {ECO:0000305}.
FT   CONFLICT    518    518       P -> L (in Ref. 6; BAB55238).
FT                                {ECO:0000305}.
FT   STRAND       59     67       {ECO:0000244|PDB:5ES1}.
FT   STRAND       69     78       {ECO:0000244|PDB:5ES1}.
FT   TURN         79     81       {ECO:0000244|PDB:5ES1}.
FT   STRAND       84     91       {ECO:0000244|PDB:5ES1}.
FT   HELIX        92     94       {ECO:0000244|PDB:5ES1}.
FT   HELIX        97    111       {ECO:0000244|PDB:5ES1}.
FT   STRAND      121    126       {ECO:0000244|PDB:5ES1}.
FT   STRAND      128    135       {ECO:0000244|PDB:5ES1}.
FT   HELIX       143    150       {ECO:0000244|PDB:5ES1}.
FT   HELIX       155    174       {ECO:0000244|PDB:5ES1}.
FT   STRAND      186    189       {ECO:0000244|PDB:5ES1}.
FT   STRAND      195    197       {ECO:0000244|PDB:5ES1}.
FT   TURN        219    221       {ECO:0000244|PDB:5ES1}.
FT   HELIX       224    228       {ECO:0000244|PDB:5ES1}.
FT   HELIX       235    251       {ECO:0000244|PDB:5ES1}.
FT   HELIX       261    270       {ECO:0000244|PDB:5ES1}.
FT   HELIX       281    290       {ECO:0000244|PDB:5ES1}.
FT   TURN        295    297       {ECO:0000244|PDB:5ES1}.
FT   HELIX       301    304       {ECO:0000244|PDB:5ES1}.
FT   HELIX       308    311       {ECO:0000244|PDB:5ES1}.
FT   HELIX       332    339       {ECO:0000244|PDB:5ES1}.
FT   TURN        340    342       {ECO:0000244|PDB:5ES1}.
FT   HELIX       345    352       {ECO:0000244|PDB:5ES1}.
FT   TURN        353    355       {ECO:0000244|PDB:5ES1}.
FT   HELIX       359    366       {ECO:0000244|PDB:5ES1}.
FT   TURN        367    369       {ECO:0000244|PDB:5ES1}.
SQ   SEQUENCE   752 AA;  82520 MW;  4B430FFD2B150E7A CRC64;
     MSSRTVLAPG NDRNSDTHGT LGSGRSSDKG PSWSSRSLGA RCRNSIASCP EEQPHVGNYR
     LLRTIGKGNF AKVKLARHIL TGREVAIKII DKTQLNPSSL QKLFREVRIM KGLNHPNIVK
     LFEVIETEKT LYLVMEYASA GEVFDYLVSH GRMKEKEARA KFRQIVSAVH YCHQKNIVHR
     DLKAENLLLD AEANIKIADF GFSNEFTLGS KLDTFCGSPP YAAPELFQGK KYDGPEVDIW
     SLGVILYTLV SGSLPFDGHN LKELRERVLR GKYRVPFYMS TDCESILRRF LVLNPAKRCT
     LEQIMKDKWI NIGYEGEELK PYTEPEEDFG DTKRIEVMVG MGYTREEIKE SLTSQKYNEV
     TATYLLLGRK TEEGGDRGAP GLALARVRAP SDTTNGTSSS KGTSHSKGQR SSSSTYHRQR
     RHSDFCGPSP APLHPKRSPT STGEAELKEE RLPGRKASCS TAGSGSRGLP PSSPMVSSAH
     NPNKAEIPER RKDSTSTPNN LPPSMMTRRN TYVCTERPGA ERPSLLPNGK ENSSGTPRVP
     PASPSSHSLA PPSGERSRLA RGSTIRSTFH GGQVRDRRAG GGGGGGVQNG PPASPTLAHE
     AAPLPAGRPR PTTNLFTKLT SKLTRRVADE PERIGGPEVT SCHLPWDQTE TAPRLLRFPW
     SVKLTSSRPP EALMAALRQA TAAARCRCRQ PQPFLLACLH GGAGGPEPLS HFEVEVCQLP
     RPGLRGVLFR RVAGTALAFR TLVTRISNDL EL
//
